MARKET

BK-PRC

BNY MELLON
BK-PRC
NYSE
Delisted
P/E
P/S
P/B
MARKET CAP
5.55
1.343
0.4936
582,966,000.00
Health Canada Approves Yorvipath by Ascendis Pharma for Chronic Hypoparathyroidism
Reuters · 3d ago
Health Canada genehmigt Yorvipath von Ascendis Pharma für die Behandlung von chronischem Hypoparathyreoidismus
Reuters · 3d ago
Cibus Partners with John Innes Centre for Precision Breeding Initiative
Reuters · 3d ago
Huntington Bancshares ernennt Senthil Kumar zum neuen Chief Risk Officer
Reuters · 4d ago
ANALYSIS-Big US banks boost Washington lobbying muscle as policy fights heat up
Reuters · 4d ago
Ascendis Pharma A/S to Announce Full Year 2025 Financial Results and Business Update
Reuters · 5d ago
Ascendis Pharma A/S kündigt Veröffentlichung der Jahresergebnisse und Geschäftsupdate an
Reuters · 5d ago
BNY MELLON MUNICIPAL BOND INFRASTRUCTURE FUND, INC. (NYSE: DMB) ANNOUNCES DISTRIBUTION
Reuters · 6d ago
More

Webull offers BNY MELLON stock information, including NYSE: BK-PRC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BK-PRC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BK-PRC stock methods without spending real money on the virtual paper trading platform.